Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

985
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
985
Glial Cells01:04

Glial Cells

96.1K
Overview
96.1K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

3.0K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.0K
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

5.6K
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
5.6K
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

1.9K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Darkness modifies brain cell proliferation and behavior in female Austrolebias reicherti fish.

The Journal of experimental biology·2026
Same author

Incidence and outcomes of adolescent pregnancy in consuelo, Dominican Republic between 2017-2022.

International journal of adolescent medicine and health·2025
Same author

Pericyte pannexin1 controls cerebral capillary diameter and supports memory function.

Nature communications·2025
Same author

Mitochondrial morphology in fertile and infertile men: image processing and morphometric analysis of the sperm midpiece.

Frontiers in cell and developmental biology·2025
Same author

Adult neurogenesis in the Uruguayan teleost species Austrolebias charrua and Gymnotus omarorum.

Neuroscience·2025
Same author

Neurovascular unit impairment in iron deficiency anemia.

Neuroscience·2024

Related Experiment Video

Updated: Mar 14, 2026

Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein
10:59

Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein

Published on: June 6, 2025

1.2K

Astrocyte Dysfunction in Developmental Neurometabolic Diseases.

Silvia Olivera-Bravo1, Eugenia Isasi2, Anabel Fernández3

  • 1Cellular and Molecular Neurobiology, Instituto de Investigaciones Biológicas Clemente Estable (IIBCE), Montevideo, Uruguay. solivera@iibce.edu.uy.

Advances in Experimental Medicine and Biology
|October 8, 2016
PubMed
Summary

Astrocyte dysfunction contributes to developmental neurometabolic disorders, particularly glutaric acidemia type I. Targeting astrocytes may offer new therapeutic strategies for these challenging brain conditions.

Keywords:
Astrocyte dysfunctionAstrocytesMyelin damageNeurodegenerationNeurodevelopmental diseases

More Related Videos

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
11:42

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

5.5K
Generation of Human Brain Organoids for Mitochondrial Disease Modeling
08:09

Generation of Human Brain Organoids for Mitochondrial Disease Modeling

Published on: June 21, 2021

6.9K

Related Experiment Videos

Last Updated: Mar 14, 2026

Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein
10:59

Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein

Published on: June 6, 2025

1.2K
In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
11:42

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

5.5K
Generation of Human Brain Organoids for Mitochondrial Disease Modeling
08:09

Generation of Human Brain Organoids for Mitochondrial Disease Modeling

Published on: June 21, 2021

6.9K

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Metabolic Disorders

Background:

  • Astrocytes are vital for brain homeostasis and neural development.
  • Altered astrocyte functions are implicated in various developmental neurometabolic disorders.
  • Glutaric acidemia type I is a neurometabolic neurodegenerative disease with significant astrocyte involvement.

Purpose of the Study:

  • To review astrocyte function alterations in developmental neurometabolic disorders.
  • To highlight the role of astrocyte dysfunction in glutaric acidemia type I.
  • To explore therapeutic strategies targeting astrocytes for neurometabolic diseases.

Main Methods:

  • Literature review of astrocyte functions in neurometabolic disorders.
  • Analysis of data on glutaric acidemia type I and astrocyte dysfunction.
  • Discussion of current and potential therapeutic approaches.

Main Results:

  • Astrocyte dysfunction is a key factor in the pathogenesis of developmental neurometabolic disorders.
  • Specific data confirms the predominant role of astrocytes in glutaric acidemia type I.
  • Astrocytes represent a promising target for novel therapeutic interventions.

Conclusions:

  • Understanding astrocyte roles is critical for addressing neurometabolic diseases.
  • Therapeutic strategies focused on astrocytes hold potential for treating these disorders.
  • Further research into astrocyte-targeted therapies is warranted.